The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients

The DONATE HCV trial demonstrated the safety and efficacy of transplanting hearts from hepatitis C viremic (HCV+) donors. In this report, we examine the cost-effectiveness and impact of universal HCV+ heart donor eligibility in the United States on transplant waitlist time and life expectancy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Woolley, Ann E., Gandhi, Aditya R., Jones, Michelle L., Kim, Jane J., Mallidi, Hari R., Givertz, Michael M., Baden, Lindsey R., Mehra, Mandeep R., Neilan, and Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065819/
https://www.ncbi.nlm.nih.gov/pubmed/36525554
http://dx.doi.org/10.1097/TP.0000000000004378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065819/
https://www.ncbi.nlm.nih.gov/pubmed/36525554
http://dx.doi.org/10.1097/TP.0000000000004378

Ejemplares similares